WC, U., AT, H., R, M., SE, J., MB, S., K, K., . . . NJ, C. (1992). A phase II study of piritrexim in patients with advanced squamous head and neck cancer. Cancer, 69(4), 1008. https://doi.org/10.1002/1097-0142(19920215)69:4<1008::aid-cncr2820690430>3.0.co;2-h
Chicago Style (17th ed.) CitationWC, Uen, Huang AT, Mennel R, Jones SE, Spaulding MB, Killion K, Havlin K, Keegan P, and Clendeninn NJ. "A Phase II Study of Piritrexim in Patients with Advanced Squamous Head and Neck Cancer." Cancer 69, no. 4 (1992): 1008. https://doi.org/10.1002/1097-0142(19920215)69:4<1008::aid-cncr2820690430>3.0.co;2-h.
MLA (9th ed.) CitationWC, Uen, et al. "A Phase II Study of Piritrexim in Patients with Advanced Squamous Head and Neck Cancer." Cancer, vol. 69, no. 4, 1992, p. 1008, https://doi.org/10.1002/1097-0142(19920215)69:4<1008::aid-cncr2820690430>3.0.co;2-h.